Navigation Links
FDA Approves First Supplemental Test for Chagas Disease
Date:11/18/2011

SILVER SPRING, Md., Nov. 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first test for use as an additional, more specific test on human serum or plasma specimens found to be positive for antibodies to Trypanosoma cruzi (T. cruzi). T. cruzi causes Chagas disease, a serious and potentially fatal parasitic infection.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

The test, called the ABBOTT ESA Chagas [Trypanosoma cruzi (E. coli, Recombinant) Antigen], is an in vitro enzyme strip assay for the qualitative detection of antibodies to T. cruzi. There are currently two donor screening tests licensed to detect antibodies to T. cruzi; however, this will be the first test licensed as a supplemental test.

"This test will help health care professionals to provide counseling to donors with positive screening test results," said Karen Midthun, M.D., director of the FDA's Center for Biologics Evaluation and Research.

Chagas disease is mainly spread by blood-sucking insects infected with T. cruzi. Chagas disease can also be spread through blood transfusion, organ transplants, and from mother to unborn child. The estimated number of persons living in the United States infected with T. cruzi, and at risk for developing Chagas disease, is 300,000 or more.

More than 5,000 donors with positive test results on a screening test have been identified since national screening of the blood supply was instituted in early 2007.

The Abbott ESA Chagas assay is manufactured by Abbott Laboratories, based in Abbott Park, Ill.

For more information:
Trypanosoma cruzi (T. cruzi) (Anti-T.
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Erwinaze to Treat a Form of Leukemia
2. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
3. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
4. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
5. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
6. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
7. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
8. FDA Approves Onfi To Treat Severe Type of Seizures
9. FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA®
10. FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
11. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 Today, ... Inc. (NASDAQ: GILD ), Health Management Associates Inc. ... IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ... access these reports free of charge - including full price ... below. Gilead Sciences, Inc. Research Report ...
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/17/2013)... 17, 2013 Velplex, LLC announced this week ... platform that connects buyers and sellers of discount ... leader. Why? It,s because the business ... familiar with the dental industry. They have 50 years ... diligently worked to negotiate some of the best prices ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
... SHENZHEN, China , April 30 ... or the "Company"), a leading manufacturer of,medical dressings, medical disposables and ... that it,closed its previously announced public offering of 1,380,000 shares of ... ...
... VIEW, Calif. , April 30 IRIDEX Corporation, (Nasdaq: ... 532 laser systems. The IQ 532 is a high-power, 532 nm, dual ... diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma; and for ... , , ...
Cached Medicine Technology:Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 2Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 3Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 4IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems 2
(Date:6/19/2013)... 19, 2013 To survive when your plane goes ... veteran Captain W.S. “Bud” Orr, the most important item in a ... Sharon Kleyne on the Sharon Kleyne Hour Power of Water radio ... he always placed extra water ahead of guns or even food. ... survival kits that pilots could carry on planes in Vietnam. He ...
(Date:6/19/2013)... 2013 In honor of women everywhere, ... providing information that women can use to improve their ... women should pay close attention to their health, as ... changes a woman’s body undergoes while pregnant can increase ... says Dr. Ray Workman, a leading vein doctor at ...
(Date:6/19/2013)... 2013 According to Vanessa Grigoriadis, a ... “psychonauts” are creating new designer drugs featuring psychoactive effects ... published documents and patented formulas. She reported her findings ... on June 4. , “Some of these drugs ... tested on humans. Maybe some of them are tested ...
(Date:6/19/2013)... As more and more people realize the ... energy-saving products to replace those unhealthy traditional lamps. Zhontian ... a variety of products to meet customers' needs. Apart ... and LED spot lights , the new product ... to customers by Zhongtian Lighting recently. This model uses ...
(Date:6/19/2013)... 2013 Indosoft Inc., developers of ... for Asterisk, announced today the availability of its ... offers improved options for extracting, consolidating and presenting ... contact center management. , Large Asterisk based contact ... it happens from the call center software. This ...
Breaking Medicine News(10 mins):Health News:Vietnam Navy Pilot Reveals to Radio Host Sharon Kleyne That He Carried Extra Water Not a Gun in Survival Kit 2Health News:Novant Health Vein Specialists Promotes Women’s Health with Social Media Campaign 2Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:3W High Power LED Down Light [ZT-D70-311F] Is Introduced to Customers by Zhongtian Lighting 2Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2
... , DALLAS, Dec. 11 They feature real patients, ... Care System,s advertising campaign titled "Real Patients, Real Stories" ... Media,s annual awards event held in Chicago this fall. ... United, to create the non-traditional spots. The documentary-style ads ...
... with the greatest reduction in child casualties, according to research ... Road traffic injuries are a leading cause of death and ... contribution to public health burdens over the coming decades, especially ... has a comparatively good road injury record, with among the ...
... Circulating metastatic breast cancer cells can lose their epithelial receptors, ... undetected, according to research from The University of Texas M. ... at the CTRC-AACR San Antonio Breast Cancer Symposium. Levels ... from a primary tumor or its metastases - have been ...
... take drugs that could prevent another blood clot, study ... of ischemic stroke survivors don,t take medications that can reduce ... , Ischemic stroke is caused by blocked blood flow in ... of another ischemic stroke. These include blood thinners (antithrombotic medications), ...
... , GAINESVILLE, Fla., Dec. 11 ... amazing regenerative power of salamanders, trying to understand how ... humans and other mammals paralyzed -- or worse. , ... Health Grand Opportunity grant of $2.4 million, a multi-institutional ...
... , PHILADELPHIA, Dec. 11 Autism research led by scientists ... top ten medical breakthroughs of 2009 by Time Magazine. ... the largest-ever genetic study of autism spectrum disorders (ASDs), published in April ... Hakonarson, M.D., Ph.D., director of the Center for Applied Genomics at the ...
Cached Medicine News:Health News:Baylor Health Care System's Patient Testimonial Ad Campaign Wins National Award 2Health News:More 20 mph zones in London would prevent 100 killed or seriously injured casualties each year 2Health News:Novel detection method unmasks circulating breast cancer cells 2Health News:Novel detection method unmasks circulating breast cancer cells 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4Health News:Autism Research at the Children's Hospital of Philadelphia Is Among Time Magazine's Top 10 Medical Breakthroughs 2
... kit is an enzyme immunometric assay ... a liquid phase,incubation, designed for the ... The microplate is coated,with anti-rabbit antibodies.,Calibrators ... anti-rabbit antibody-coated wells, along with rabbit ...
Myoglobin RIA Lipid / Protein Quantification, Cardiovascular 024-IDC-11 Muscle Disease...
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy...
Medicine Products: